cbdMD Statistics
Total Valuation
cbdMD has a market cap or net worth of $5.47 million. The enterprise value is $5.56 million.
| Market Cap | 5.47M |
| Enterprise Value | 5.56M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
cbdMD has 11.21 million shares outstanding. The number of shares has increased by 382.43% in one year.
| Current Share Class | 11.21M |
| Shares Outstanding | 11.21M |
| Shares Change (YoY) | +382.43% |
| Shares Change (QoQ) | +1.66% |
| Owned by Insiders (%) | 2.66% |
| Owned by Institutions (%) | 16.31% |
| Float | 10.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| Forward PS | 0.24 |
| PB Ratio | 0.66 |
| P/TBV Ratio | 0.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.50, with a Debt / Equity ratio of 0.27.
| Current Ratio | 2.50 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 28.33 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -40.33% and return on invested capital (ROIC) is -20.74%.
| Return on Equity (ROE) | -40.33% |
| Return on Assets (ROA) | -15.75% |
| Return on Invested Capital (ROIC) | -20.74% |
| Return on Capital Employed (ROCE) | -28.84% |
| Weighted Average Cost of Capital (WACC) | 11.54% |
| Revenue Per Employee | $498,368 |
| Profits Per Employee | -$73,324 |
| Employee Count | 42 |
| Asset Turnover | 1.82 |
| Inventory Turnover | 2.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.16% in the last 52 weeks. The beta is 2.17, so cbdMD's price volatility has been higher than the market average.
| Beta (5Y) | 2.17 |
| 52-Week Price Change | -27.16% |
| 50-Day Moving Average | 0.61 |
| 200-Day Moving Average | 0.79 |
| Relative Strength Index (RSI) | 38.57 |
| Average Volume (20 Days) | 182,157 |
Short Selling Information
The latest short interest is 527,696, so 4.71% of the outstanding shares have been sold short.
| Short Interest | 527,696 |
| Short Previous Month | 550,098 |
| Short % of Shares Out | 4.71% |
| Short % of Float | 4.84% |
| Short Ratio (days to cover) | 2.33 |
Income Statement
In the last 12 months, cbdMD had revenue of $20.93 million and -$3.08 million in losses. Loss per share was -$0.32.
| Revenue | 20.93M |
| Gross Profit | 12.07M |
| Operating Income | -2.90M |
| Pretax Income | -2.89M |
| Net Income | -3.08M |
| EBITDA | -1.89M |
| EBIT | -2.90M |
| Loss Per Share | -$0.32 |
Balance Sheet
The company has $2.12 million in cash and $2.21 million in debt, with a net cash position of -$93,925 or -$0.01 per share.
| Cash & Cash Equivalents | 2.12M |
| Total Debt | 2.21M |
| Net Cash | -93,925 |
| Net Cash Per Share | -$0.01 |
| Equity (Book Value) | 8.21M |
| Book Value Per Share | 0.74 |
| Working Capital | 4.62M |
Cash Flow
In the last 12 months, operating cash flow was -$2.22 million and capital expenditures -$191,419, giving a free cash flow of -$2.41 million.
| Operating Cash Flow | -2.22M |
| Capital Expenditures | -191,419 |
| Depreciation & Amortization | 1.02M |
| Net Borrowing | 61,990 |
| Free Cash Flow | -2.41M |
| FCF Per Share | -$0.22 |
Margins
Gross margin is 57.68%, with operating and profit margins of -13.87% and -13.80%.
| Gross Margin | 57.68% |
| Operating Margin | -13.87% |
| Pretax Margin | -13.80% |
| Profit Margin | -13.80% |
| EBITDA Margin | -9.01% |
| EBIT Margin | -13.87% |
| FCF Margin | n/a |
Dividends & Yields
cbdMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -382.43% |
| Shareholder Yield | -382.43% |
| Earnings Yield | -56.32% |
| FCF Yield | -44.06% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 7, 2025. It was a reverse split with a ratio of 1:8.
| Last Split Date | May 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
cbdMD has an Altman Z-Score of -17.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.07 |
| Piotroski F-Score | 3 |